Skip to main content
. 2025 Jun 16;13:RP96803. doi: 10.7554/eLife.96803

Table 2. Demographic characteristics and descriptive questionnaire measures in the early and late chronotype participants.

Early chronotype Late chronotype Significance
Sample size (%) 102 (51.78%) 95 (48.22%)
Demographics
Age, mean (SD; range) 51.80 (14.10; 20–78) 35.80 (14.40; 19–68) p < 0.001
Gender, number (%) p < 0.05
Male 42 (41.18) 55 (57.89)
Female 60 (58.82) 40 (42.11)
Testing time
Start testing time, number (%) p < 0.01
Morning testing (8:00–11:59) 63 (31.98) 38 (19.29)
Evening testing (18:00–21:59) 39 (19.80) 57 (28.93)
Psychiatric comorbidities
Current or past, number (%)
Any 22 (21.60) 40 (42.10) p < 0.01
Major depressive disorder 4 (3.92) 22 (23.16) p < 0.001
Generalized or social anxiety disorder 18 (17.65) 24 (25.26) p = 0.258
Current antidepressant use, number (%) 9 (8.82) 26 (27.40) p < 0.1
Psychiatric questionnaire measures
SHAPS, mean (SD; range) 9.65 (6.38) 11.80 (5.92) p < 0.05
DARS, mean (SD; range) 54.00 (9.37) 52.70 (9.39) p = 0.322
AES, mean (SD; range) 56.00 (9.72) 50.60 (10.10) p < 0.001
M.I.N.I., current MDD (%) 3 (2.94) 15 (15.79) p < 0.01

Note. SES, subjective socioeconomic status; IQR, interquartile range; SHAPS, Snaith–Hamilton Pleasure Scale; DARS, Dimensional Anhedonia Rating Scale; AES, Apathy Evaluation Scale; M.I.N.I., Mini-International Neuropsychiatric Interview; MDD, major depressive disorder; MEQ, Morningness–Eveningness Questionnaire; MCTQ, Munich Chronotype Questionnaire; BMI, body mass index; FINDRISC, Finish Diabeted Risc Score.